CrushSCI.com
Journal Selection & Manuscript Polishing Services
ADVANCED DRUG DELIVERY REVIEWS journal cover Medicine
Back to journal directory

Review Cycle Records

ADVANCED DRUG DELIVERY REVIEWS

Elsevier SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
137.3Average days
135.5Median days
60Fastest days
226Longest days
1402025 publications

Paper Review Records

All Paper Review Records

12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

137 days

The intersection of engineered live biotherapeutics, the microbiome, and drug delivery

AuthorsNathan Crook; Juliane Nguyen

AffiliationsDepartment of Chemical and Biomolecular Engineering, North Carolina State University, 840 Main Campus Drive, Raleigh, NC 27606, USA; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA,

Source PDF DOI Publisher page
126 days

Pharmacokinetic modeling and quantitative prediction of subcutaneous absorption of antibody-based therapeutics – An update

AuthorsAnna Siemiątkowska; Celine Park; Leonid Kagan

AffiliationsDepartment of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806 Poznań, Poland; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA; Center of Excellence for Pharmaceutical Translational Research and Education, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA

Source PDF DOI Publisher page
157 days

Guiding the spatial organization of engineered heart tissues

AuthorsGarrett F. Beeghly; Amid Shakeri; Fatemeh Mirzapour-Shafiyi; Caner Dikyol; Nils Offen; Alaa Alsaafin; Ulrike A. Nuber; Milica Radisic

AffiliationsInstitute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada; Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada; Integrative Tissue Biology Lab, Department of Biology, Technical University of Darmstadt, Darmstadt, Germany; Stem Cell and Developmental Biology, Technical University of Darmstadt, Darmstadt, Germany; Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada; Acceleration Consortium, University of Toronto, Toronto, Canada; Centre for Research and Applications in Fluidic Technologies, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; The Heart and Stroke/Richard Lewar Center of Excellence, University of Toronto, Toronto, ON, Canada

Source PDF DOI Publisher page
95 days

From implantable to wearable: recent advances in microfluidic platforms for precision drug delivery

AuthorsFatma Moawad; Shihao Pei; Alfonso Nieto-Argüello; Davide Brambilla

AffiliationsFaculté de Pharmacie, Université de Montréal, 2940 Chemin de Polytechnique, Montréal, Québec H3T 1J4, Canada; Faculty of Pharmacy, Beni-Suef University, Beni-Suef 625617, Egypt; School of Pharmaceutical Sciences, University of Geneva, 24 rue du Général-Dufour, 1211 Geneva, Switzerland

Source PDF DOI Publisher page
226 days

Spatial patterning of biomimetic signals in corneal regeneration

AuthorsLexie W.Q. Xi; Zhuojian Look; Clemence Bonnet; Mehrnoosh Maalhaghfard; Sheyla González; Gaya Shnayder; Andri K. Riau; Gary S.L. Peh; Sophie X. Deng; Evelyn K.F. Yim; Jodhbir S. Mehta

AffiliationsDepartment of Chemical Engineering, University of Waterloo, Waterloo, ON, N2L 3G1, Canada; Regenerative Therapy Research Group, Singapore Eye Research Institute, Singapore 169856, Singapore; Ophthalmology and Visual Sciences Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore; Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; Molecular Biology Institute, University of California, Los Angeles, CA, USA; Centre for Biotechnology and Bioengineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada; Waterloo Institute for Nanotechnology, University of Waterloo, Waterloo, ON N2L 3G1, Canada; Corneal and External Eye Disease Department, Singapore National Eye Centre, Singapore 168751, Singapore

Source PDF DOI Publisher page
99 days

Scalable process technologies for human pluripotent stem cells (hPSCs) expansion and differentiation

AuthorsKevin Cyrys; Robert Zweigerdt

AffiliationsLeibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic Transplantation and Vascular Surgery (HTTG), Hannover Medical School (MHH), Carl Neuberg-Str. 1, Hannover 30625, Germany; REBIRTH Research Center for Translational and Regenerative Medicine, Hannover Medical School (MHH), Carl Neuberg-Str. 1, Hannover 30625, Germany

Source PDF DOI Publisher page
163 days

Toward bioengineered muscle–fat microphysiological systems for sports medicine and obesity therapeutics

AuthorsMin Young Kim; Anicca D. Harriot; Deok-Ho Kim

AffiliationsDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205, United States; Center for Microphysiological Systems, Johns Hopkins University, Baltimore, MD 21205, United States; Division of Geriatrics and Gerontology, Johns Hopkins University, Baltimore, MD 21205, United States; Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD 21205, United States; Institute for NanoBio Technology, Johns Hopkins University, Baltimore, MD 21218, United States; Department of Neurology, Johns Hopkins University, Baltimore, MD 21205, United States; Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, United States

Source PDF DOI Publisher page
134 days

Redox modulation of antitumor immunity via nanomedicine

AuthorsXuanbo Zhang; Changrong Shi; Pei Huang; Xiaoyuan Chen

AffiliationsSchool of Pharmaceutical Sciences, Hainan Medical University, Haikou, Hainan 571199, China; Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, 119074, Singapore; Center for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Jinan 250117, China.

Source PDF DOI Publisher page
175 days

Cowpea mosaic virus as a candidate for intratumoral immunotherapy: progress, challenges, and future directions

AuthorsAyumi E. Pottenger; Anthony O. Omole; Nicole F. Steinmetz

AffiliationsAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California, San Diego, La Jolla, CA, USA; Shu and K. C. Chien and Peter Farrell Collaboratory, University of California, San Diego, La Jolla, CA, USA; Center for Nano-ImmunoEngineering, University of California, San Diego, La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA; Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; Center for Engineering in Cancer, Institute of Engineering Medicine, University of California, San Diego, La Jolla, CA, USA; Department of Radiology, University of California, San Diego, La Jolla, CA, USA; Institute for Materials Discovery and Design, University of California, San Diego, La Jolla, CA, USA

Source PDF DOI Publisher page
112 days

High-Dose Subcutaneous Administration of Biologics: Overcoming Barriers Through Formulation and Device Innovation

AuthorsTarik A. Khan; Deep Bhattacharya; Twinkle R. Christian; Melissa Holstein; Xiaoqing Hua; Roshan James; Bowen Jiang; Alexander Josowitz; Danielle Laiacona; Shrenik Mehta; Apurva More; Edel Mullen; Matthew Myers; Brendon Ricart; Timon Rickenbacher; Yongchao Su; Naveen Kumar Reddy Yaragudi

AffiliationsPharma Technical Development, Hoffmann-La Roche Ltd, Basel, Switzerland; BioTherapeutics Pharmaceutical Sciences, Pharmaceutical Research and Development, Pfizer, Andover, MA, United States; Process Development Attribute Sciences and Drug Product Technologies, Amgen, Thousand Oaks, CA, United States; Biologics Development, Bristol Myers Squibb, Devens, MA, United States; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, United States; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States; Formulation and Process Development, Pre-Pivotal Biologics, Gilead Sciences Inc., Foster City, CA, United States; Pharmaceutical Development, Genentech, Inc., South San Francisco, CA, United States; Drug Product Development, Takeda, Lexington, MA, United States; Drug Product Technologies, Amgen, Cambridge, MA, United States; Analytical Development, Biologics CMC, Teva Branded Pharmaceutical Products R&D LLC, West Chester, PA, United States; Biologics CMC, Development Sciences, AbbVie, North Chicago, IL, United States; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, NJ, United States; Global Process Development, Johnson & Johnson Innovative Medicine, Malvern, PA, United States

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.